Hypertension
Conditions
Brief summary
The purpose of this study is to asses the efficacy and safety of Telmisartan depending on the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and to asses patients compliance to the therapy with Telmisartan in relation to use of electronic therapy monitoring device.
Interventions
Primary care clinic hypertensive patients for whom physician decided to start the treatment with telmisartan
Sponsors
Bang & Olufsen Medicom
Bayer
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age over 18 * Untreated or ineffectively treated arterial hypertension
Exclusion criteria
* Cholestatic disorders and severe hepatic failure * Allergy to Telmisartan * Pregnancy and lactation period * Unwillingness to participate in the study * Inability to use the drug reminder device * Unwillingness to use the drug reminder device
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy and safety of the treatment with telmisartan reported by the physician with regard to usage the HelpingHand device | At all four planned control visits. (Approx. interval between visits 3 months) |
Secondary
| Measure | Time frame |
|---|---|
| Compliance with the treatment calculated on the basis of by HelpingHand and patients questionnaires | At all four planned control visits. (Approx. interval between visits 3 months) |
Countries
Poland, Slovakia
Outcome results
None listed